03 April 2026: Clinical Research
Risk Factors for Upper Urinary Tract Stone Recurrence: A Retrospective Study of 247 Patients
Tong Wu BCDEF 1,2, Chiyu Zhao BCD 2, Shiyu Mao DOI: 10.12659/MSM.951175
Med Sci Monit 2026; 32:e951175
Abstract
BACKGROUND: Urolithiasis, as a common disease in urology, has high incidence and recurrence rates. Although there are various treatments and most patients can receive minimally invasive treatment such as ureteroscopic lithotripsy, the high recurrence rate still carries a large disease burden. To explore the potential risk factors, we conducted this retrospective study to evaluate laboratory and demographic factors associated with recurrence of upper urinary tract stones within 3 years in 247 patients.
MATERIAL AND METHODS: We performed a retrospective analysis of 247 patients who underwent surgical treatment for upper urinary tract stones at Shanghai Tenth People’s Hospital from June 2019 to December 2021, among whom 133 patients had at least 1 recurrence within 3 years. Basic information, medical history, blood test results, and urine test results were collected to explore the association of the risk factors with recurrence of upper urinary tract stones. Patients were assigned to either the recurrence group or the n-recurrence group. We analyzed the baseline levels of the 2 groups, and multivariate logistic regression was performed to assess potential risk factors.
RESULTS: Variables with P value less than 0.05 in single-factor analysis were included in the multifactor analysis. In multivariate logistic regression, the results showed that C-reactive protein-albumin-lymphocyte index and serum creatinine level are risk factors of recurrence of upper urinary tract stones (P<0.05).
CONCLUSIONS: Patients who underwent surgery for upper urinary tract stones for the first time who had a low C-reactive protein albumin lymphocyte (CALLY) index and high serum creatinine level were at higher risk of recurrence at least once within 3 years.
Keywords: Creatinine, inflammation, Recurrence, urolithiasis, Ureohydrolases, Urine, Recurrence, Muscle Fatigue, Astacoidea, Retrospective Studies
Introduction
Urinary stones are one of the most common urological conditions, with a high prevalence rate in adults worldwide [1,2]. In the past 30 years, the global incidence rate of urolithiasis increased by 48.57% [3]. Studies showed that possible contributing factors include the increasing prevalence of obesity and diabetes, changes in dietary habits, and global warming [4–7]. The main symptoms of urinary stones are pain, hematuria, dysuria, fever, nausea, and vomiting [8,9]. CT is the first-line and the most important imaging modality for diagnosis of urolithiasis [9]. In recent years, with the development of minimally invasive surgeries such as ureteroscopic lithotripsy and percutaneous nephrolithotomy, the necessity for open surgical procedures like laparoscopic ureterolithotomy is largely reduced. However, some patients undergo a second surgery because of recurrence of urinary stones [10–13]. Rule et al reported that the recurrence rate is 20% in 5 years and 50% in 10 years [12]. The high recurrence rate of urinary stones causes enormous health care expenditures, excess illness, and reduced quality of life [14–16]. Thus, it is important to prevent the recurrence of urinary stones in clinical practice [17,18].
Some factors have been reported to be associated with recurrence of urinary stones, including climate, socioeconomic status, surgical methods, and use of drugs [12,14,19–21]. While strategies to prevent urinary calculi (eg, pharmacological interventions and lifestyle modifications) have been widely recommended, the incidence rate remains high and many patients require a second surgery due to recurrence.
The ROKS2014 nomogram was the first predictive model for stone recurrence [12], but it was focused more on renal calculi, and there is a lack of research specifically focusing on Asian populations.
In clinical studies, hematological indicators are frequently used to reflect patients’ inflammatory levels, nutrition status, and immune function. Some studies showed that inflammation, nutrition status, and immune function are associated with formation of urinary stones [22–27]. The C-reactive protein-albumin-lymphocyte (CALLY) index is a comprehensive biomarker that integrates C-reactive protein (CRP), albumin levels, and lymphocyte count to assess inflammation, immunological status, and nutrition status [28,29]. Dai et al reported that CALLY index values had an inverse association with formation of kidney stones [30], but the association with recurrence of upper urinary tract stones is unknown.
Few studies have assessed the relationship of patients’ characteristics during their first hospitalization for surgery due to upper urinary tract stones with recurrence. Therefore, we conducted this retrospective study and evaluated the laboratory and demographic factors of 247 patients during their first hospitalization for surgery due to upper urinary tract stones to explore the potential risk factors for recurrence.
Material and Methods
ETHICS APPROVAL:
This study received approval from the Medical Ethics Committee of Shanghai Tenth People’s Hospital of Tongji University (No. 25K69), and was conducted in strict adherence to the principles outlined in the Declaration of Helsinki. Given the retrospective characteristic of our study, we obtained a waiver of informed consent from the local institutional review board.
DATA SOURCE AND PARTICIPANTS:
We collected clinical data of patients with kidney or urinary calculi admitted to the Department of Urology, Shanghai Tenth People’s Hospital of Tongji University, China, from June 2019 to December 2021. All cases were diagnosed with urolithiasis by 1 or more imaging examinations such as urinary system color Doppler ultrasound, CT, or various endoscopies.
We enrolled patients with upper urinary tract stones who underwent first-time surgery using percutaneous nephrolithotomy (PCNL), ureteroscopic lithotripsy (URS), flexible ureteroscopic lithotripsy (fURSL), or laparoscopic ureterolithotomy (LU). An upper urinary tract stone was defined as a calculus located in the kidney and/or ureter (Figure 1 kidney stone and Figure 2 ureteral stone). The exclusion criteria were: (1) patients not diagnosis with urolithiasis for the first time; (2) age <18 years old; (3) patients without recurrence of urinary stones but the follow-up time was less than 3 years; and (4) patients with tumor, end-stage renal disease, congenital malformation of the kidneys or ureter.
OUTCOME DEFINITION:
Patients involved in this study were followed up at least once every 6 months to determine whether there was a recurrence of stones through clinical manifestations and imaging examinations. The study outcome was the recurrence of upper urinary tract stones within 3 years, confirmed by imaging examination. We additionally set an interval limit of the recurrence time for over 3 months. The recurrence criteria were defined as the existence of a new stone or the growth of a residual stone by more than 2 mm after surgery, diagnosed by imaging examination.
COVARIATE DEFINITION:
We collected data from the hospital information system on patient characteristics, including age, sex, body mass index (BMI), and diagnosis, as well as other covariates that may be associated with the recurrence of urinary stones: hypertension, diabetes mellitus, CRP (C-reactive protein), white blood cell count, platelet count, neutrophils count, lymphocyte count, monocyte count, serum albumin, serum creatinine, serum uric acid, serum calcium, serum magnesium, serum phosphorus, urine leukocyte esterase, urinary nitrite, urinary protein, urinary glucose, urine occult blood, ureteral stricture, and ureteral polyps. The neutrophil-to-lymphocyte ratio (NLR) was calculated using the formula: NLR=neutrophil count/lymphocyte count. The platelet-to-lymphocyte ratio (PLR) was calculated using the formula: PLR=platelet count/lymphocyte count. The lymphocyte-to-monocyte ratio (LMR) was calculated using the formula: LMR=lymphocyte count/monocyte count. The neutrophil-to-platelet ratio (NPR) was calculating using the formula: NPR=neutrophil count/platelet count. The systemic immune-inflammation index (SII) was calculated using the formula: SII=platelet count*neutrophil count/lymphocyte count. The systemic inflammation response index (SIRI) was calculated using the formula: SIRI=neutrophil count*monocyte count/lymphocyte count. The C-reactive protein-albumin-lymphocyte index (CALLY index) was determined as: serum albumin level (g/L) * absolute lymphocyte count (*109 cells/L)/(CRP *10) (mg/L) [29,31].
STATISTICAL ANALYSIS:
SPSS statistical software was used to analyze and process the research data. Data are expressed as percentages. Group comparisons were performed using the chi-squared test, as appropriate. Multivariate logistic regression analyses were performed to explore associations between these factors and recurrence. Multicollinearity among risk factors was assessed using the variance inflation factors (VIF), with a VIF value exceeding 10 indicating a multicollinearity concern.
Results
BASELINE CHARACTERISTICS OF THE STUDY PARTICIPANTS:
We collected hospital records of 308 patients who were diagnosis with upper urinary stone and received surgical treatment in Shanghai Tenth People’s Hospital. According to the exclusion criteria, 61 were excluded. Finally, 247 patients with upper urinary tract stone were eligible for the present analysis, among whom 133 patients experienced at least 1 symptomatic recurrence of upper urinary stone within 3 years after the first surgery.
First, we divided patients into 2 or more groups for each factor. For BMI, we divided patients into 3 groups with a boundary of 24 and 28. For factors that could be detected in our hospital and provided a reference range, such as white blood cell count, platelet, CRP, serum calcium, serum potassium, serum phosphorus, and serum magnesium, the classification criteria were according to the reference range. For composite factors such as SII, NLR, PLR, LMR, NPR, SIRI, CALLY index, serum creatinine, and serum uric acid, the classification criteria were according to the optimal cut-off value derived from the ROC curve. The optimal cut-off value was identified according to the Youden index, which maximized the Youden index. The cut-off values of SII, NLR, PLR, LMR, NPR, SIRI, CALLY index, serum creatinine, and uric acid are listed in Table 1. As shown in Table 2, 163 male patients and 84 female patients were included in this study, and 98 male patients and 35 female patients had recurrence of upper urinary stones within 3 years. The results showed that the sex distribution was different between the 2 groups. The factors reflecting inflammation status such as SII and NLR were higher in the recurrence group. Then, we used chi-square analysis to screen out potential factors associated with recurrence, showing that sex, SII, NLR, LMR, NPR, SIRI, CALLY index, serum creatinine level, serum uric acid level, and ureter polyps were associated (P<0.05).
FACTORS ASSOCIATED WITH RECURRENCE OF UPPER URINARY STONES:
After collinearity testing, variables with P value less than 0.05 in the single-factor analysis were included in the multifactor analysis. The results (Table 3) showed that the VIF values of all factors were less than 10, suggesting that the collinearity between these variables was weak. Then, to find the independent influencing factors, we performed binary multifactor logistic regression, showing that CALLY index and serum creatinine level were the independent influencing factors (P<0.05) (Table 4).
Discussion
This retrospective cohort study investigated the association between clinically accessible biomarkers and 3-year recurrence rate of upper urinary tract stones. Multivariate analysis revealed that patients with lower CALLY index and higher serum creatinine levels results had significantly higher recurrence risks compared to those with higher CALLY index and normal serum creatinine levels results (
The CALLY index is a comprehensive indictor that integrates nutritional status (albumin), systemic inflammatory response (CRP), and immune status (lymphocyte count). A few studies have reported that the CALLY index score is associated with the prognosis of diseases, including tumors, cardiovascular disease, and ulcerative colitis [29,35–38]. Some studies reported that inflammation may have a positive effect in the formation of urinary stones [22,39,40] However, factors reflecting the inflammation status, such as CRP, WBC, SII, and SIRI, were not independent influencing factors in our study, while the CALLY index was. In our study, patients with low CALLY index had a higher probability of recurrence. CALLY index components showed distinct patterns: hypoalbuminemia, lymphopenia, and elevated CRP in the recurrence group. This tripartite indicator may reflect persistent subclinical inflammation and an impaired mucosal defense mechanism, potentially facilitating stone formation. Consistent with our findings, Shoag et al found that CRP had a significant relationship with self-reported kidney stones [41].
Notably, serum creatinine, known as an indicator of renal function, is also an independent risk factor [42]. Keller et al found that patients with chronic kidney disease (CKD) had higher risk of urinary stones [43]. High serum creatinine can reflect worsening kidney function, with abnormal renal concentration and excretion, which can alter the balance between urinary stone formation and clearance.
However, there are some other potential indicators. Daudon et al explored the relationship between stone composition and recurrence, finding that uric acid stones had a higher recurrence rate than other types of stones [33]. They also found that the recurrence of phosphate stones was associated with infection, and the recurrence rate would be decreased if the infection was successfully treated [33]. Lifestyle may also be an important factor influencing the recurrence of urinary stones. Siener reported that changing the pH value of urine through diet was an important factor influencing the recurrence of urinary stones [44].
Our findings suggest that recurrence of upper urinary stones within 3 years after surgery is associated with renal function and inflammatory conditions, and CALLY index scores and serum creatinine levels are relative risk factors. Multicenter prospective clinical studies are needed to confirm whether CALLY index scores and serum creatinine levels are predictors of recurrence of upper urinary tract stones.
This study has some limitations. Firstly, as a retrospective study, some information came from the dictation and surgery records, such as hypertension, ureter stricture, and polyps, and these records may not be accurate, and the analytical method was rather simple and could not determine a causal relationship. Secondly, many patients had incomplete follow-up, reducing the sample size, and this could limit the validity of our conclusions. Thirdly, we did not assess all information possibly associated with the recurrence of upper urinary stones, such as details about stones.
Conclusions
Patients who underwent first-time surgery for upper urinary tract stones and who had a lower CALLY index scores and higher serum creatinine levels were at higher risk for recurrence of upper urinary tract stones at least once within 3 years.
References
1. Romero V, Akpinar H, Assimos DG, Kidney stones: A global picture of prevalence, incidence, and associated risk factors: Rev Urol, 2010; 12(2–3); e86-96
2. Scales CD, Smith AC, Hanley JM, Saigal CS, Prevalence of kidney stones in the United States: Eur Urol, 2012; 62(1); 160-65
3. Zhu C, Wang DQ, Zi H, Epidemiological trends of urinary tract infections, urolithiasis and benign prostatic hyperplasia in 203 countries and territories from 1990 to 2019: Mil Med Res, 2021; 8(1); 64
4. Bargagli M, Scoglio M, Howles SA, Fuster DG, Kidney stone disease: Risk factors, pathophysiology and management: Nat Rev Nephrol, 2025; 21(11); 794-808
5. Scales CD, Tasian GE, Schwaderer AL, Urinary stone disease: Advancing knowledge, patient care, and population health: Clin J Am Soc Nephrol, 2016; 11(7); 1305-12
6. Malieckal DA, Goldfarb DS, Occupational kidney stones: Curr Opin Nephrol Hypertens, 2020; 29(2); 232-36
7. Bishop K, Momah T, Ricks J, Nephrolithiasis: Prim Care, 2020; 47(4); 661-71
8. He M, Dong Y, Cai W, Recent advances in the treatment of renal stones using flexible ureteroscopys: Int J Surg, 2024; 110(7); 4320-28
9. Ludwig WW, Matlaga BR, Urinary stone disease: diagnosis, medical therapy, and surgical management: Med Clin North Am, 2018; 102(2); 265-77
10. Hesse A, Brändle E, Wilbert D, Study on the prevalence and incidence of urolithiasis in Germany comparing the years 1979 vs. 2000: Eur Urol, 2003; 44(6); 709-13
11. Huang WY, Chen YF, Carter S, Epidemiology of upper urinary tract stone disease in a Taiwanese population: A nationwide, population based study: J Urol, 2013; 189(6); 2158-63
12. Rule AD, Lieske JC, Li X, The ROKS nomogram for predicting a second symptomatic stone episode: J Am Soc Nephrol, 2014; 25(12); 2878-86
13. Thongprayoon C, Krambeck AE, Rule AD, Determining the true burden of kidney stone disease: Nat Rev Nephrol, 2020; 16(12); 736-46
14. Ferraro PM, Curhan GC, D’Addessi A, Gambaro G, Risk of recurrence of idiopathic calcium kidney stones: analysis of data from the literature: J Nephrol, 2017; 30(2); 227-33
15. New F, Somani BK, A complete world literature review of quality of life (QOL) in patients with kidney stone disease (KSD): Curr Urol Rep, 2016; 17(12); 88
16. Saigal CS, Joyce G, Timilsina AR, Direct and indirect costs of nephrolithiasis in an employed population: Opportunity for disease management?: Kidney Int, 2005; 68(4); 1808-14
17. Pearle MS, Goldfarb DS, Assimos DG, Medical management of kidney stones: AUA guideline: J Urol, 2014; 192(2); 316-24
18. Türk C, Petřík A, Sarica K, EAU guidelines on diagnosis and conservative management of urolithiasis: Eur Urol, 2016; 69(3); 468-74
19. Dhayat NA, Bonny O, Roth B, Hydrochlorothiazide and prevention of kidney-stone recurrence: N Engl J Med, 2023; 388(9); 781-91
20. Iremashvili V, Li S, Best SL, Hedican SP, Nakada SY, Clinical and demographic predictors of repeat stone surgery: BJU Int, 2019; 124(5); 836-41
21. Wang Q, Wang Y, Yang C, Surgical procedure and recurrence of upper urinary tract stone: A national-wide study based on hospitalized patients: World J Urol, 2024; 42(1); 132
22. Khan SR, Canales BK, Dominguez-Gutierrez PR, Randall’s plaque and calcium oxalate stone formation: role for immunity and inflammation: Nat Rev Nephrol, 2021; 17(6); 417-33
23. Di X, Liu S, Xiang L, Jin X, Association between the systemic immune-inflammation index and kidney stone: A cross-sectional study of NHANES 2007–2018: Front Immunol, 2023; 14; 1116224
24. Capolongo G, Ferraro PM, Unwin R, Inflammation and kidney stones: cause and effect?: Curr Opin Urol, 2023; 33(2); 129-35
25. Paz DC, Gunther AC, Higham MC, Exploring the relationship of supernumerary recurrent renal calculi formation and tick-borne infections: A case report: Front Cell Infect Microbiol, 2024; 14; 1194307
26. Zhu W, Qiong D, Changzhi X, Meiyu J, Hui L, Macrophage polarization regulation shed lights on immunotherapy for CaOx kidney stone disease: Biomed Pharmacother, 2024; 179; 117336
27. Siener R, Nutrition and kidney stone disease: Nutrients, 2021; 13(6); 1917
28. Iida H, Tani M, Komeda K, Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma: HPB (Oxford), 2022; 24(1); 101-15
29. Yang M, Lin SQ, Liu XY, Association between C-reactive protein-albumin-lymphocyte (CALLY) index and overall survival in patients with colorectal cancer: From the investigation on nutrition status and clinical outcome of common cancers study: Front Immunol, 2023; 14; 1131496
30. Dai L, Qiu C, Association between the CALLY index and kidney stones: Insights from NHANES 2007–2010: Mediators Inflamm, 2025; 2025; 9920716
31. Fan X, Qing D, Zhao J, The relationship between CALLY index and stroke in hypertensive patients: insights from NHANES: Front Nutr, 2025; 12; 1592641
32. Lyall VS, Wood KD, Pais VM, Hydrochlorothiazide and prevention of kidney-stone recurrence: N Engl J Med, 2023; 388(21); 2014
33. Daudon M, Jungers P, Bazin D, Williams JC, Recurrence rates of urinary calculi according to stone composition and morphology: Urolithiasis, 2018; 46(5); 459-70
34. Arivoli K, Valicevic AN, Oerline MK, Preventive pharmacological therapy and risk of recurrent urinary stone disease: Clin J Am Soc Nephrol, 2024; 19(5); 565-72
35. Ji H, Luo Z, Ye L, Prognostic significance of C-reactive protein-albumin-lymphocyte (CALLY) index after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: Int Immunopharmacol, 2024; 141; 112860
36. Jia P, Shen F, Zhao Q, Association between C-reactive protein-albumin-lymphocyte index and overall survival in patients with esophageal cancer: Clin Nutr, 2025; 45; 212-22
37. Xi P, Huang G, Huang K, The prognostic significance of the CALLY index in ampullary carcinoma: An inflammation-nutrition retrospective analysis: J Inflamm Res, 2025; 18; 621-35
38. Su K, Xiao S, Wang M, Predictive value of albumin to fibrinogen ratio and CALLY index for diagnosis of ulcerative colitis and mucosal healing after vedolizumab treatment: J Inflamm Res, 2025; 18; 589-600
39. Wang Q, Chen X, Huang K, S100A9 promotes renal calcium oxalate stone formation via activating the TLR4-p38/MAPK-LCN2 signaling pathway: Int J Biol Macromol, 2024; 281(Pt 1); 136178
40. Taguchi K, Okada A, Unno R, Macrophage function in calcium oxalate kidney stone formation: A systematic review of literature: Front Immunol, 2021; 12; 673690
41. Shoag J, Eisner BH, Relationship between C-reactive protein and kidney stone prevalence: J Urol, 2014; 191(2); 372-75
42. Bellomo R, Kellum JA, Ronco C, Acute kidney injury in sepsis: Intensive Care Med, 2017; 43(6); 816-28
43. Keller JJ, Chen YK, Lin HC, Association between chronic kidney disease and urinary calculus by stone location: A population-based study: BJU Int, 2012; 110(11 Pt C); E1074-78
44. Siener R, Can the manipulation of urinary pH by beverages assist with the prevention of stone recurrence?: Urolithiasis, 2016; 44(1); 51-56
Figures
Tables
Table 1. The cut-off values of variables.
Table 2. Baseline characteristics of patients.
Table 3. Collinearity test.
Table 4. Multivariate logistic regression.
Table 1. The cut-off values of variables.
Table 2. Baseline characteristics of patients.
Table 3. Collinearity test.
Table 4. Multivariate logistic regression. In Press
Clinical Research
Institutional and Regional Variations in Access to Clinical Trials and Next-Generation Sequencing in Turkis...Med Sci Monit In Press; DOI: 10.12659/MSM.951027
Clinical Research
Low-Intensity Blood Flow-Restricted Multi-Joint Exercise Improves Muscle Function in Patients With Patellof...Med Sci Monit In Press; DOI: 10.12659/MSM.950516
Review article
Musculoskeletal Ultrasound and MRI in the Evaluation of Chemotherapy-Induced Peripheral Neuropathy: A ReviewMed Sci Monit In Press; DOI: 10.12659/MSM.951283
Clinical Research
Sensory Processing, Dissociation, and Affective Symptoms in Misophonia: A Cross-Sectional Study of 35 AdultsMed Sci Monit In Press; DOI: 10.12659/MSM.950938
Most Viewed Current Articles
17 Jan 2024 : Review article 10,187,196
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
13 Nov 2021 : Clinical Research 3,708,487
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
14 Dec 2022 : Clinical Research 2,341,643
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research 706,524
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387








